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Abstract: Bacteriophage vB_EcoM_fHy-Eco03 (fHy-Eco03 for short) was isolated from a sewage
sample based on its ability to infect an Escherichia coli clinical blood culture isolate. Altogether,
32 genes encoding hypothetical proteins of unknown function (HPUFs) were identified from the
genomic sequence of fHy-Eco03. The HPUFs were screened for toxic properties (toxHPUFs) with
a novel, Next Generation Sequencing (NGS)-based approach. This approach identifies toxHPUF-
encoding genes through comparison of gene-specific read coverages in DNA from pooled ligation
mixtures before electroporation and pooled transformants after electroporation. The performance
and reliability of the NGS screening assay was compared with a plating efficiency-based method,
and both methods identified the fHy-Eco03 gene g05 product as toxic. While the outcomes of the two
screenings were highly similar, the NGS screening assay outperformed the plating efficiency assay in
both reliability and efficiency. The NGS screening assay can be used as a high throughput method in
the search for new phage-inspired antimicrobial molecules.
Keywords: bacteriophage; hypothetical proteins of unknown function; next-generation sequencing;
toxic protein screen
1. Introduction
The emergence of bacteria resistant to all currently available antibiotics is, and has
long been, managed by modifying existing drugs to re-gain effectiveness against resistant
bacteria [1]. Drug development, however, cannot keep up with bacterial evolution, as
the environment is under a constant load of antimicrobials, causing the persistence and
spread of resistance genes [2]. The development of new antibiotic classes is expensive and
often too futile, as a majority of promising candidates do not make it through the clinical
testing processes. Therefore, new sources for antimicrobial drugs are in high demand [3],
such as lytic proteins produced by bacteriophages during the infection cycle that include
virion-associated peptidoglycan hydrolases and endolysins in conjunction with holins that
have already been used to some extent as antibacterials [4,5].
Phage genomes also encode numerous proteins for which the functions and structures
are still unknown. These proteins are annotated in the sequence databases as “hypothetical
proteins with unknown function” (HPUFs). Based on previous studies, many HPUFs
include small molecules with toxic properties (toxHPUFs) that phages utilize during the
infection cycle to hamper the cellular functions and defense mechanisms of the bacterial
host [6]. Traditionally, toxic gene products have been detected by the inefficient transfor-
mation of bacterial cells with a plasmid carrying the toxin-encoding gene [6–11]. In the
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plating efficiency assay, the number of transformants obtained with the HPUF-encoding
genes is compared to the number of transformants obtained with control genes encoding
known toxic and non-toxic proteins. In practice, the PCR-amplified HPUF genes are ligated
into a plasmid vector and electroporated individually into host bacteria; the resulting
transformants are enumerated. This approach includes several difficult-to-standardize
steps that all cause day-to-day, experiment-to-experiment, and batch-to-batch variation,
even when the toxic and non-toxic controls are included in every batch. The reproducibility
can be improved by increasing the number of replicates; however, such an approach does
not allow high throughput without robotics.
In the next-generation-sequencing (NGS)-based assay described in this study, most of
these issues are avoided by transforming all the selected genes simultaneously as a pooled
ligation mixture. Using NGS read coverages, the relative abundance of correctly ligated
inserts can be determined for a pooled ligation mixture and for the plasmids isolated
from the pooled transformants. We describe and validate here the NGS screening assay
by carrying out screening with five known toxic and four non-toxic genes of phages fHe-
Kpn01 [10], φR1-RT [8], and T4 [12] and 32 HPUF-encoding genes of Escherichia phage
fHy-Eco03 in a comparative study with the plating assay [10].
2. Materials and Methods
2.1. Bacterial Strains, Bacteriophages and Culture Media
The bacteriophages and bacterial strains used in this study are listed in Table 1 and
Table S1. Plasmid pU11L4 used for cloning in this study was isolated from E. coli strain
DH10B/pU11L4. The electrocompetent DH10B and DH5α cells were prepared as described
previously [13]. All bacterial strains used in this study were grown on LB agar (1.5%, w/v)
or in LB broth supplemented with 100 µg/mL ampicillin (Sigma-Aldrich, St. Louis, MO,
USA) unless mentioned otherwise, at 35 ◦C or 37 ◦C. Transformed E. coli DH10B cells were
grown in SOC medium (0.5% yeast extract, 2% tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM
MgCl2, 10 mM MgSO4, 20 mM glucose pH 7.0) and transformed DH5α cells were grown
on M9t minimal medium (2.2 mM KH2PO4, 3.4 mM Na2HPO4, 0.94 mM NH4Cl, 0.86 mM
NaCl, 0.2% (w/v) tryptone, 2.0 mM MgSO4, 0.10 mM CaCl2 and 3.0 × 10−3 mM vitamin B1).
Table 1. Bacteriophages, bacteria, and plasmids used in this study.
Bacteriophages and Bacteria Comments Reference
Bacteriophages
ϕR1-RT PCR template for phage ϕR1-RT genes [14]
T4 PCR template for phage T4 genes [12]
fHe-Kpn01 PCR template for phage fHe-Kpn01 genes [10]
fHy-Eco03 PCR template for phage fHy-Eco03 genes This work
E. coli strains
#5509 Human blood culture isolate This work
DH10B Cloning host [15]
DH5α Cloning host [16]
DH10B/pU11L4 Source of plasmid pU11L4 [8]
2.2. Phage Isolation and Purification
fHy-Eco03 was isolated from a municipal sewage sample collected in Hyvinkää,
Finland, using clinical E. coli strain #5509 (Table 1 and Table S1) as the host. Strain #5509
was used to propagate the phage. Phage lysates were produced from semiconfluent soft-
agar plates as described elsewhere [17]. The phage lysates were then concentrated, purified
using ultracentrifugation with a glycerol step gradient [18], and stored at 4 ◦C as described
earlier [10].
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2.3. Electron Microscopy
Phage particles were sedimented by centrifugation for 2 h (16,000× g at 4 ◦C) and
resuspended in 0.1 M ammonium acetate (pH 7.2). Afterward, 200 mesh Formvar-coated
copper grids were used to allow the phage particles to sediment for 1 min. Negative
staining was done using 1% uranyl acetate at pH 4.2 (method modified from [19]). A JEOL
JEM1400 electron microscope, operated at 80 kV, and an Olympus Morada CCD camera
were used to image the phage particles (Department of Virology, University of Helsinki,
Helsinki, Finland).
2.4. Host Range Determination
The host range of fHy-Eco03 on 50 E. coli strains (Table S1) was determined by pipetting
10 µL droplets of serial dilutions of concentrated phage stocks on lawns of different bacterial
strains prepared on LB agar plates, and the plates were incubated until the next day at
37 ◦C. The double-layer method was used to confirm positive droplet test results using
phage preparations with appropriate dilutions.
Infection growth curves on phage-sensitive E. coli strains were performed as follows.
An overnight bacterial culture was diluted 500-fold in fresh LB medium, and 180 µL
aliquots were distributed into Bioscreen Honeycomb 2 plates wells (Growth Curves Ab Ltd.,
Helsinki, Finland), where they were mixed with 20 µL of different fHy-Eco03 phage stock
dilutions. The phage stock and bacterial culture were mixed to achieve multiplicity of
infection (MOI) values ranging between 0.5 and 500. The controls consisted of 180 µL of
bacterial culture and 20 µL of fresh LB medium, or just 200 µL of fresh LB medium alone.
The growth experiment was carried out at 37 ◦C using a Bioscreen C incubator (Growth
Curves Ab Ltd., Helsinki, Finland) with continuous shaking. The OD600 of the cultures was
measured every 45 min for up to 15 h. The averages were calculated from values obtained
for the bacteria grown in, at minimum, triplicate wells.
2.5. Genome Sequencing and Analysis
Phage DNA was obtained from high-titer phage preparations as described earlier [17],
and sequenced at Eurofins Genomics. The next-generation sequencing DNA library (insert
size of 625 ± 311) was paired-end sequenced using Illumina MiSeq sequencer (Illumina,
San Diego, CA, USA) with a read length of 150 nucleotides. The A5-miseq integrated
pipeline for de novo assembly of microbial genomes was used to assemble the genome
sequence [20]. The termini of the phage genome were identified using PhageTerm [21], and
confirmed by restriction digestions and comparisons to related phages. The orientation
of the genome was arranged similarly to the sequences of closely related homologs as
found in a nucleotide BLAST search. The genes were annotated with RAST software [22]
and validated manually, confirming also that the predicted genes were accompanied by a
properly located ribosomal binding site. The Geneious Prime v 11.1.5 [23] was used for
visualization of the phage genome.
A protein BLAST against the non-redundant protein sequences database (release
update from 6 February 2021) was performed for every predicted gene product and the
two results with the lowest E-values were recorded (Table S2). Furthermore, every gene
product was analyzed using HHpred [24], and the best hits with a probability above 50%
and an E-value below 1 were recorded (Table S2). The presence of tRNAs was investigated
using tRNAscan-SE [25]. In addition, ResFinder 3.1 [26] and VirulenceFinder 2.0 [27]
software were used. Phylogenetic trees of complete phage genomes at the nucleotide level
were constructed using VICTOR [28]. The complete genome sequence with annotation was
deposited in the NCBI nucleotide database (GenBank) under accession number MW602648.
2.6. Proteomics
The protein content of purified phages (as tryptic peptides) was analysed using liquid
chromatography–tandem mass spectrometry (LC-MS/MS) at the Proteomics Unit, Institute
of Biotechnology, University of Helsinki as described earlier [8,29]. Calibrated tryptic
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peptide peaks were searched against the predicted tryptic peptides from the amino acid
sequences of all, even the non-annotated, open reading frames (ORFs) in the genome of fHy-
Eco03. The proteins identified by LC-MS/MS analysis as having two or more unique tryptic
peptides and over 5% sequence coverage were annotated as phage (structural) proteins.
2.7. DNA Methods
Restriction digestions of purified fHy-Eco03 DNA were performed with restriction
endonucleases NcoI, NotI, ScaI, SphI (Thermo Fisher Scientific, Waltham, MA, USA), AflII,
EagI, Sau3AI, and SmaI (New England Biolabs, Ipswich, MA, USA) in appropriate diges-
tion buffers.
All plasmid isolations were performed with a commercial Nucleobond Xtra Midi kit
(MACHEREY-NAGEL, Düren, Germany) according to the protocol for high-copy number
plasmids. Plasmid pU11L4 was double digested with restriction enzymes NotI and NcoI,
or with NheI and NotI (Thermo Fisher Scientific, USA), if an internal NcoI site was present
in the sequence of the gene in question (Tables S3 and S4). Toxic and non-toxic control
genes (Table S3) and the HPUF-encoding (Table S4) genes of phage fHy-Eco03 were cloned
as PCR-fragments into the multiple cloning site of plasmid pU11L4 (Figure S1) with a
three-molar excess of the insert.
The recombinant plasmids were transformed to electrocompetent E. coli DH10B cells,
having a transformation efficiency of approximately 109 CFU per µg of intact pU11L4
plasmid. The electroporation was performed in 0.2 mm cuvettes (Bulldog Bio, Portsmouth,
NH, USA) by combining approximately 10 ng of the recombinant vector to 45 µL of
electrocompetent DH10B cells. The pulse was given with a Gene Pulser™ apparatus
(Bio-Rad Laboratories, Hercules, CA, USA), with the settings of 200 Ω, 25 uF and 2.5 kV.
Transformed cells were suspended immediately in 950 µL of SOC medium and incubated
at 35 ◦C for 1 h in slow rotation; afterwards, 50 µL was pipetted on LB ampicillin plates.
Plates were incubated overnight at 37 ◦C. Transformations of the HPUF-encoding genes of
fHy-Eco03 were done in batches of 4 to 6 genes with the g178 gene of phage ϕR1-RT as a
non-toxic control in each batch [8,10]. The relative CFUs were determined from triplicate
platings of two biological replications per gene.
For the NGS screening assay, the individual fHy-Eco03 HPUF-encoding gene ligations
were combined to pooled samples in two batches, containing all the HPUF-encoding genes,
without any control genes. The pooled ligation mix samples were purified and concentrated
with NucleoSpin® Gel and a PCR Clean-up kit (MACHEREY-NAGEL, Germany) according
to instructions, and eluted in 20 µL; 1 µL was used for electroporation as described above.
After the initial 1 hr incubation in SOC, the whole suspension was spread in 50 µL aliquots
on twenty LB ampicillin plates and grown overnight at 37 ◦C. All the obtained transformant
colonies were pooled together, and the pool was grown aerated to the late logarithmic
phase in ampicillin supplemented SOC (3 h at 37 ◦C). Plasmid isolation from the culture
was carried out as described above using the Nucleobond Xtra Midi kit.
2.8. Bioinformatics
The NGS-based screening approach is outlined in Figure 1. The ligation mixture and
transformant samples containing plasmid DNA were sequenced with the 150 bp paired-end
protocol in the Illumina HiSeq platform at NovoGene (UK). Successful ligation between
the HPUF-gene carrying PCR-fragment and the plasmid vector generates ligation joints
that in NGS will be sequenced from both strands, resulting in four kinds of sequence reads
over the ligation joints (Figure 1b).
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The raw sequencing read data were screened for the presence of the four expected
sequences for each gene. To identify these reads, we generated in silico a list of ligation-joint
covering sequences that included 15–25 nucleotides of specific sequence from both sides
of the ligation joint (Figure 1b). The number of reads over the joints (joint-reads) reflects
the number of intact and correctly ligated genes in the samples. The relative number of
joint-reads of a specific gene was then calculated as a percentage of the total joint-reads
in the sample. A toxic gene can be identified by a significant reduction in the relative
number of the gene-specific joint-reads in the transformant plasmid pool compared to the
relative number in the pooled ligation mixture. The complete pipeline of the bioinformatics
analysis is described in detail in Table S5. The sequence analysis was performed using the
Puhti computer at CSC (the Finnish Centre for Scientific Computing).
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2.9. Protein Function and Sequence Analysis
The predicted functions and structures of protein sequences were obtained by model-
ing the protein sequence with Phyre 2 software [30] and aligning against protein sequence
databases with BLASTx [31,32].
2.10. Confirmation of Toxicity by Growth Curve Analysis
The putative toxHPUF-encoding genes were selected to further confirm the toxic-
ity. Genes were cloned into the multiple cloning site of the arabinose-inducible plasmid
pBAD30. Plasmid and genes were digested with the KpnI and XbaI enzymes or SphI
(Thermo Fisher Scientific, Waltham, MA, USA) if an internal Xbal site was present in the
insert. An aliquot of each ligation mixture was transformed into electrocompetent E. coli
DH5α cells as described earlier. Transformant colonies were selected and further grown
overnight in an LB medium supplemented with ampicillin and glucose (0.2% w/v).
The constructs were confirmed by Sanger sequencing at the Finnish Institute for
Molecular Medicine (FIMM). After overnight incubation, the cells were washed with M9t
minimal medium and 10 µL was inoculated into the M9t medium supplemented with
ampicillin and either glucose (0.2% w/v) or arabinose (0.2% w/v). Bacterial cells were
distributed to Bioscreen Honeycomb plates and the OD600 was measured every hour for
20 h with Bioscreen C MBR (Oy Growth Curves Ab Ltd., Helsinki, Finland). Average ODs
and standard deviation were measured from triplicate wells of three biological replicates
per gene. As controls, E. coli strains carrying plasmids containing phage ϕR1-RT toxic or
non-toxic (g137 and g150) genes, or with the empty vector were used.
3. Results
3.1. fHy-Eco03 Host Range and Growth Characteristics
Phage fHy-Eco03 was isolated from a municipal sewage sample collected in Hyvinkää,
Finland, using human E. coli isolate #5509 (Table 1) as the host. The genome size (57 kb),
size of the prolate capsid (86 nm long), and the length of the tail (103 nm) of fHy-Eco03
(Figure S2) are characteristics of a dwarf Myovirus.
The host range experiments revealed that fHy-Eco03 has a relatively narrow host
range, as it was able to produce clear lysis only in two (#5509 and #5517) of the 50 tested
clinical strains (Table S1). In addition, strain #5520 was infected with low efficiency of
plating (EOP); in eight strains (e.g., #5522), turbid plaques were produced. It should be
noted that the clear plaques that fHy-Eco03 formed in its original host strain were small
(Figure S3). Of note, fHy-Eco03 was found to infect a recent E. coli isolate from a patient
suffering from a chronic urinary tract infection, and it was used in compassionate phage
therapy treatment.
The killing efficiency of fHy-Eco03 was examined with four E. coli strains. The strains
were infected in liquid culture at different MOI values, and the bacterial growth curves
were determined. The results showed that fHy-Eco03 infected efficiently strains #5509,
#5517, and, to our surprise, also strain #5522, and prevented growth in the cultures for 6–7 h
after which the growth of apparently phage-resistant mutants became evident (Figure S4).
No growth inhibition was seen with the low EOP strain #5520.
3.2. General Genomic Features of fHy-Eco03
The genome sequence was assembled using 250,000 reads with an average whole-
genome coverage of 646x. The length of the double-stranded DNA genome is 57,011 bp with
a GC-content of 45.1%. Restriction digestions were carried out with 10 different enzymes
that had between 3 and 14 recognition sites in genomic sequence (Figure S5). Only ScaI was
able to digest the DNA and the generated restriction fragments accommodate perfectly
the in silico-predicted fragments (Figure S5). The methylation sensitivity or dependence of
the used restriction enzymes could not explain the failure of the other enzymes to digest
the DNA (Figure S5), suggesting that DNA carries an unknown modification that blocks
the enzymes. Future work is required to elucidate the nature of the modification. Direct
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terminal repeats of 3699 bp were identified from the genome ends by the PhageTerm
tool [21] (Figure S6). The terminal repeats were predicted to contain 11 genes.
The fHy-Eco03 genome is predicted to encode for 81 genes with ATG as an initiation
codon for 74 of the predicted genes, followed by TTG for four and GTG for three predicted
genes. The overall organization of the genome (Figure S7) is almost identical to closely
related phages (Figure 2 and Figure S8). Apart from the terminal repeats that encode 11 pre-
dicted genes, the fHy-Eco03 genome is bipartite, with genes from g12 to g48 transcribed
in the forward direction and genes from g49 to g78 from the reverse strand. Close to the
right terminal repeat, g79 and g80 are again transcribed in the forward direction in close
proximity to g01 and g02 of the right terminal repeat. Of note, the proteomic analysis
identified with high confidence peptides encoded in an open reading frame inside gene
g53; we named this extra gene, g53.1 (Table S6, Figure S7).
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Initially, based on BLASTp search, most of the predicted gene products of fHy-Eco03
were annotated as HPUFs with no similarity to characterized proteins. Purified fHy-Eco03
particles were analyzed using the LC-MS/MS to identify the phage-particle-associated
proteins (PPAPs), and altogether, 48 phage proteins were identified as PPAPs (Table S6).
As the genome encodes 81 predicted gene products, and 48 were assigned as PPAPs, of the
remaining 33 gene products, 25 were identified as true HPUFs since Gp23, Gp26, Gp40,
Gp50, Gp54, Gp64, Gp65, and Gp72 showed homology to known proteins in HHpred
analysis (Table S2).
The VIPtree server [33] was used to generate a phylo enetic tree indicating that
the phage is most closely related to Salmonella phage BP63 (Figure 2). Whole genome
nucleotide sequence megablast searches were carried out to identify the closely related
phages from databases. Their phylogenetic relationships were determined using the Victor
tool [28] demonstrating that fHy-Eco03 positions close to a number of other Salmonella
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phages (Figure S8). This allowed us to classify fHy-Eco03 as a member of the Rose-
mountviruses [34]. Genome alignment of fHy-Eco03 with the Salmonella phage BP63
is shown in Figure 2b, demonstrating the close relatedness over the full lengths of the
phage genomes. The calculated coding density for fHy-Eco03 was 83.4%, which is a bit
lower than that seen in other members of the Rosemountviruses or the also closely related
Loughboroughviruses [34]. As no genes encoding integrase, lysogeny, virulence or antimi-
crobial resistance-associated proteins were identified in the genome of phage fHy-Eco03,
based on current opinion, the phage is considered safe for use in phage therapy.
3.3. Identification of toxHPUFs by Plating Efficiency and NGS-Based Screening Assays
Some of the HPUFs of fHy-Eco03 potentially encode toxic proteins. Previously, the
plating efficiency assay was used to identify toxic HPUFs [8,10], but this assay is not
optimal in terms of reproducibility and efficiency. Therefore, we set up an NGS-based
screening assay to identify toxic proteins. Known toxic and non-toxic phage gene products,
five each originating from Escherichia phage T4, Yersinia phage ϕR1-RT, and Klebsiella phage
fHe-Kpn01 (Table S4) were first tested in the plating efficiency assay to assess whether
the previously published results were reproducible [8,10]. This was indeed the case as the
non-toxic controls produced between ~200 (g150) and ~700 (g178) transformants, and the
toxic controls between 5 (regB) and ~100 (g137) transformants (Figure 3, Table S7).
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g10  0.86  0.13  0.15 
g22  3.10  0.07  0.02 
g38  14.84  26.83  1.81 
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Figure 3. Comparison of t xicity screeni gs with cont s. (a) The plating efficiency as ay shows the average numbers
(±SD) of transformants for non-toxic (g178, g119, g121, g246 and g150) and toxic (g137, g38, g22, g10 and regB) control genes
(Table S3), based on two biological replicates with triplicate platings for each gene (Table S7). (b) In the NGS screening assay,
the percentages of the joint-reads for each gene were calculated relative to the total joint-reads for both the pooled ligation
mixture and the pooled plasmids from the transf r ants. Shown are the ratios f th percentages in he p asmid DNA of
transformants versus those in the ligation mixture. A toxic gene should produce a ratio significantly below 1 (see Table S8
for details). The bars show for means ± SD for two replicate transformations.
The relative toxicities of the same genes were then tested with the NGS screening assay
as illustrated in Figure 1a. The control genes were ligated independently into the cloning
vector. The ligation mixtures were then pooled together, and an aliquot was withdrawn for
NGS, and then the ligation pool was electroporated into E. coli. The obtained transformants
were pooled and the isolated plasmid DNA was subjected to NGS. The ligation joint-
reads were then extracted from both types of DNA samples as described (Table S5). The
proportions of gene-specific joint-reads for each gene among all extracted reads were
calculated for both types of samples. Theoretically, a toxic gene would not establish itself as
a plasmid among the transformants, and, therefore, would have no or very few joint-reads
among the extracted plasmid DNA join-reads. Conversely, the relative proportion of the
joint-reads of non-toxic genes could even increase. For each gene, the joint-read percentage
in the plasmid sample was divided by the joint-read percentage in the pooled ligation
mixture (Figure 3b, Table S8). Unfortunately, no regB specific joint-reads were detected in
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any of the samples, suggesting that its ligation mix was either destroyed or accidentally
omitted from the pool. The joint-read ratios of the toxic control genes g10, g22, g38, and
g137 were 0.15, 0.02, 1.8, and 27.2, respectively, and those of the non-toxic control genes
g119, g121, g150, g178, and g246 were 1.68, 5.63, 0.19, 0.48, and 0.44, respectively (Figure 3b,
Table S8). Based on these results, the NGS screening would have identified only the g10
and g22 gene products as toxic candidates.
When preparing the ligation mixtures, each ligation reaction contained the same
amount of vector DNA, and equimolar amounts of PCR-fragments. Therefore, in an
optimal situation, the numbers of gene-specific joint-reads should be equal for each gene in
the pooled ligation mix—in this experiment with ten genes, 10%. However, the joint-read
percentages in the original ligation mixture varied between 0.48% for g137 and 23.11%
for g246 (Table 2), indicating that ligation efficiencies between the genes varied a lot. As
the vector DNA in all ligations were the same, a possible explanation for the variation
has to be in the properties and/or the quality of the PCR-fragments that influence the
ligation efficiency.
Table 2. The gene-specific joint-read percentages from total joint-reads extracted from the NGS





Ligation Mixture Transformant Sample
g10 0.86 0.13 0.15
g22 3.10 0.07 0.02
g38 14.84 26.83 1.81
g119 11.70 19.53 1.67
g121 2.79 15.74 5.63
g137 0.48 13.16 27.2
g150 21.38 3.81 0.18
g178 21.74 10.58 0.49
g246 23.11 10.17 0.44
Total 100 100
Even keeping this in mind, the unexpectedly high ratio of g137 cannot be accounted
for, especially as it demonstrated moderate toxicity in the plating assay (Figure 3a) and
apparently no toxicity in the NGS screening assay. Analysis of the aligned sequence reads
from the plasmid samples against the gene g137 sequence demonstrated that the cloned
gene g137 sequence was intact. Therefore, keeping in mind that the pooled ligation mixture
included altogether six phage ϕR1-RT genes, there is a possibility of a co-transformation
of the host bacteria with two or more different plasmids at the same time. In such a case,
in ordinary situations without any selective pressure, only one plasmid per offspring of
the co-transformant would be carried further. In the case of transformants carrying the
g137-containing plasmid, the toxicity of Gp137 would generate a selective pressure. Thus,
a plausible explanation for the observed phenomenon could be that the g137 carrying
transformants was co-transformed with a plasmid carrying a gene encoding an anti-toxin.
Thus, when inspecting the joint-read number percentages, the co-transformed gene should
have at least the same percentage as g137 (13.16%) and perhaps even higher, as it would
also survive as an individual non-toxic transformant. Only two of the ϕR1-RT genes
fulfilled this requirement, g119 and g121 that have joint-read number percentages of 19.53
and 15.74, respectively (Table 2). Interestingly, the increase in the percentage between the
ligation and plasmid samples is close to 13% for both g121 and g137, while it is only 8%
for g119. Whether Gp137 and Gp119 or Gp121 make a toxin and anti-toxin system can be
easily tested by co-transforming those genes together to a host bacterium.
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3.4. Screening the fHy-Eco03-Encoded HPUF Genes
The plating efficiency assay was used in parallel with the NGS screening assay to
screen 23 HPUF-encoding genes of fHy-Eco03. In addition, 9 more HPUF-encoding genes
were screened using the NGS assay only (Table 3, Table S9 and S10). For the plating
efficiency assay, the number of transformants was normalized to the non-toxic gene g178,
which was included as a control in each batch of electroporations (Table 3). The ratios
ranged from 0.16 of g05 to 1.71 of g48. In addition to g05, the ratios of six genes (g52, g64,
g51, g68, g10, and g65) were below 0.6, indicating a potentially toxic gene.
Table 3. Comparison of NGS and plating assay results for the fHy-Eco03 HPUF encoding genes. For the NGS screening
assay, shown are the percentages of the gene-specific joint-reads in the ligation mix and the plasmid DNA samples, and
the plasmid/ligation ratios calculated based on them. The data have been determined from two biological replicates of
the pooled ligation mixtures and two replicate transformations per mixture (details in Tables S9 and S10). The average
fractions in the plating assay were determined by dividing the average number of transformants for each gene with that of
the non-toxic control gene g178 processed in the same batch. The plating assay was carried out with two biological replicates
and triplicate platings. Potentially toxic ratios are highlighted in grey. Genes chosen for further screening are given in bold.
NGS Screening Assay Results Plating Assay Results
Gene % Reads inLigation Mix
% Reads in
Plasmid DNA Ratio SD Gene
Fraction of
g178 SD
g01 1.31 3.52 2.69 0.114 g01 0.680 0.166
g03 1.26 5.33 4.22 0.546 g03 1.003 0.015
g04 0.89 2.93 3.30 0.167 g04 0.672 0.035
g05 3.36 0.01 0.003 0.001 g05 0.164 0.003
g06 1.46 3.56 2.43 0.328 g06 0.684 0.193
g08 1.28 3.85 3.01 0.196 g08 0.658 0.130
g09 2.80 4.30 1.53 0.027 g09 0.827 0.145
g10 1.08 1.63 1.50 0.334 g10 0.463 0.186
g11 1.07 2.97 2.78 0.043 g11 0.901 0.250
g13 2.87 5.71 1.99 0.202 g13 1.179 0.428
g15 8.64 5.21 0.60 0.074 g15 1.104 0.349
g17 7.79 5.49 0.71 0.014 g17 0.868 0.224
g18 36.90 41.23 1.12 0.017 – – –
g23 12.09 3.28 0.27 0.005 g23 0.683 0.200
g26 19.23 12.80 0.67 0.055 – – –
g40 11.47 3.63 0.32 0.036 – – –
g48 3.40 15.39 4.52 0.288 g48 1.711 0.106
g50 2.67 4.08 1.53 0.099 g50 0.746 0.234
g51 0.91 5.41 5.96 0.072 g51 0.440 0.180
g52 6.75 3.81 0.56 0.033 g52 0.332 0.089
g58 0.96 0.33 0.34 0.056 – – –
g59 2.36 17.27 7.32 1.827 – – –
g61 2.71 9.41 3.47 0.047 – – –
g64 7.91 2.07 0.26 0.024 g64 0.332 0.089
g65 5.39 5.40 1.00 0.049 g65 0.515 0.140
g68 1.31 1.06 0.81 0.034 g68 0.451 0.077
g69 8.18 5.62 0.69 0.023 g69 0.795 0.237
g71 11.59 10.57 0.91 0.059 – – –
g72 4.08 2.43 0.59 0.064 – – –
g73 10.71 2.34 0.22 0.019 – – –
g76 3.94 4.60 1.17 0.068 g76 1.296 0.505
g77 11.44 4.77 0.42 0.051 g77 0.974 0.481
For the first batch of the NGS screening assay, the ligation mixtures of the 23 HPUF-
encoding genes of fHy-Eco03 were pooled together and electroporated to the host bacteria.
In the second batch, the ligation mixtures of the remaining nine HPUF-encoding genes
were pooled together and electroporated. Details of both batches are given in Table S10,
and summarized in Table 3. Theoretically, each gene should be represented in the first
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ligation batch with a 4.3% share, and in the second batch with an 11.1% share. The results
show that the shares ranged between 0.89 and 11.44% for batch 1, and 0.96 and 36.90% for
batch 2, indicating that also here, the genes had not ligated with equal efficiency, again
possibly due to variation in the properties and quality of the PCR products.
The ratios between the ligation mix and the plasmid DNA joint-read percentages
ranged between 0.003 and 7.32 (with a mean ± SD of 1.76 ± 1.78). As the ratio below 1.0
should indicate toxicity and taking into account the variation in ligation efficiencies, we
chose to consider genes with ratios around or below 0.5 as toxic candidates. Altogether,
seven genes were in this group, with four of them also tested in the plating efficiency assay
(Table 3). Considering both these screening assay results, the gene products of g05, g10,
g23, g40, g51, g52, g58, g64, g68, g73, and g77 demonstrated some toxicity in one or both of
the assays, with only Gp05 clearly presenting the most toxicity in both assays.
The numbers of NGS joint-reads for each alignment are displayed in detail in Table S10.
While sequence coverages of complementary fragments were equal in the DNA samples of
the plasmids isolated from pooled transformants, the corresponding reads from the ligation
mixture varied substantially. The difference between read coverages of complementary
fragments varied consistently up to a thousand-fold, as in some cases, only a few to zero
reads were obtained (Tables S8 and S10). Apparently, due to the short size of the gene
fragments, there is a bias in the generation of the DNA library for NGS that distorts the
distribution of the sequence reads, favoring those that start from the plasmid side.
3.5. Gp05 Showed Toxicity among the Tested toxHPUF Candidates of fHy-Eco03
The growth-inhibition potential of the phage fHy-Eco03 gene products Gp05, Gp23,
Gp51, Gp52, Gp64, and Gp68 was tested with a growth curve analysis by cloning each
gene into an arabinose-inducible pBAD30 vector. Absorbances (OD600) measured during
arabinose induced or glucose inhibited expression during a 20-h incubation are presented
in Figure 4. The growth of the arabinose-induced Gp05 expressing cells was inhibited in
a similar manner to that of the toxic control Gp137 of ϕR1-RT [8], thus confirming the
toxicity of Gp05 to E. coli. The other gene products of fHy-Eco03 demonstrated, at best,
only moderate growth inhibition, exemplified by Gp68 (Figure 4a). The glucose-repressed
cultures all showed a steady exponential growth (Figure 4b). It must be noted that the
toxicity screen of fHy-Eco03 HPUFs was not exhaustive, as all the possible toxHPUF
candidates with ratios below 0.5 identified in Table 3 were not included in this experiments.
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Figure 4. Growth curves f . lls containing pBAD30 plasmid with cloned fHy-Eco03 candidate toxHPUF
encoding genes, during (a) arabinose induced or (b) glucose inhibited expression. Average OD600 values were determined
from triplicate wells of three biological replicates.
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3.6. Functional and Structural Analysis of Gp05
Gp05 is predicted to be an 81 amino-acid-long protein that is 68–78% identical to
five HPUFs of closely related Salmonella phages, with the highest identity to Gp60 of
phage ZCSE2 (Accession number MK673511, Figure S8). In addition, the N-terminal half
of Gp05 showed some similarity to the C-terminal parts of the ca. 700 amino-acid-long
ATP-dependent helicases of several different bacteria. Interestingly, modeling with Phyre2
software [30] resulted in a model with 73.60% confidence for the 39 N-terminal residues of
Gp05 against the residues 670–710 of the 780 amino-acid-long helicase RecG (PDB 1GM5)
(Figure 5) of Thermotoga maritima [35]. These residues are located in the C-terminal domain
3 of the RegG protein that is involved in ATP binding, and are very close to the region that
interacts with the DNA structure [35].
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Figure 5. Protein structure and sequence alignment of Gp05, modeled with Phyre2 software.
4. Discussion
In this study, we describe a new NGS-based screening assay for the detection of
bacteriophage-encoded toxic proteins. The performance of the NGS screening assay was
compared with the previously used plating assay by screening known toxic and non-toxic
genes and the HPUFs of phage fHy-Eco03. Among the fHy-Eco03 HPUFs, the Gp05 was
found to be toxic in both the screening assays and the growth inhibition assay. The amino
acid sequence of Gp05 showed 68–78% identity to five HPUFs of Salmonella phages. Despite
fHy-Eco03 being isolated in E. coli, Salmonella and Escherichia bacteria are closely related
species; indeed, it is not surprising that the structure and function of Gp05 and the obtained
proteins were similar. The N-terminal half of Gp05 was best modeled by Phyre2 against the
fold present in RecG, an ATP-dependent helicase. The RecG protein was first described for
E. coli. It functions in resolving stalled replication forks, and RecG homologs can be found
in a majority of bacterial species. RecG is an essential, multifunctional protein involved in
several DNA repair and replication-related pathways, thus it would be a good target for
the bacteriophage-mediated arrest of cellular functions [36–38]. It is tempting to speculate
that the Gp05 toxicity could be mediated by its ability to interfere the RecG activity. To
further characterize the structure, mechanisms, and cellular targets of Gp05, comprehensive
protein–protein interaction studies are required. This involves expression and purification
of the toxic protein, which is often challenging because of possible toxic and deleterious
effects to the bacterial production host. In such a case, as an alternative, yeast and plant
cells could be used as the production host, or the toxic properties and targets could be
identified through an in vitro translation approach.
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Hypothetical proteins have previously been screened with interaction studies be-
tween known bacterial targets and hypothetical proteins [11], or by cloning shotgun
sheared genomes [9] and annotated hypotheticals [6] into inducible expression vectors.
Van Den Bossche et al. discovered eight bacteriotoxic proteins by screening 32 hypothet-
ical proteins of seven different phages against cellular targets of Pseudomonas aeruginosa
by utilizing affinity chromatography [11]. However, since toxic proteins are discovered
through interactions with specific targets, proteins with unknown cellular targets are in-
evitably overlooked. In a study conducted by Singh et al., seven Siphovirus genomes were
sheared and cloned to inducible vectors and screened for toxic effects in two Mycobac-
terium strains [9]. Two toxic proteins and two synthetic peptides were discovered with this
approach. The peptides, however, had unnatural ORFs, pointing out the disadvantage
of this method. By using sheared genomes, the risk of producing vector constructs with
either fragmented ORFs or incorrectly oriented genes increases and these can easily be
interpreted as false positives or negatives. A similar expression vector-based approach was
used by Liu et al. with the difference of first identifying true hypotheticals for screening.
With this method, 31 protein families with toxic properties were identified from 27 different
Staphylococcus phages [6].
The plating assay used in the present study as a reference method is similar to the
approach used by Liu et al. [6]. Since many PPAPs are not identified by bioinformatics tools,
we first identified them by LC-MS/MS analysis carried out on purified phage particles, and
only then, the remaining HPUFs were screened for toxic ones using the plating efficiency
assay [8,10]. The HPUF-encoding genes are cloned to an expression vector and transformed
into electrocompetent E. coli cells by electroporation. Toxic properties were identified by
comparing transformation efficiencies against cells transformed with a vector containing
a non-toxic control gene. Although this method minimizes the amount of genes to be
screened, it still has several drawbacks that reduce the reliability and repeatability of the
results, as many steps of the screening approach are hard if not impossible to control and
standardize. Firstly, surviving transformants can be generated by undigested or self-ligated
plasmids, or by gene fragments that are incorrectly ligated to the vector plasmid. Secondly,
electroporation conditions in which the cells are transformed cannot be reliably controlled,
thus are not ideal for quantitative experiments such as this. Finally, the results are affected
by variations in temperature, pipetting, and plating. In order to increase the reliability and
reproducibility, the HPUFs had to be screened with several replicate batches together with
control genes. While this did decrease the variation, the required amount of resources and
time increased almost exponentially.
The performance of the NGS screening assay was first tested by conducting an ex-
periment with five non-toxic and five toxic genes of phages fHe-Kpn01 [10], T4 [39], and
ϕR1-RT [8]. The plating efficiency assay confirmed that RegB of T4, Gp137 of ϕR1-RT, and
Gp10, Gp22, and Gp38 of fHe-Kpn01 were toxic. In the parallel NGS-based screening assay,
however, only Gp10 and Gp22 showed toxicity. The regB ligation, due to an unknown
technical error, dropped out from the pooled ligation mixture, thus leaving the unexpected
results of Gp38 and Gp137 unaccounted for. The possibility of co-transformation of an
anti-toxin expressing gene was already discussed for Gp137 (Section 3.4), and this could
also be the case for Gp38. As a conclusion, it has to be noted that the interpretation of
the NGS-based assay results may face unknown challenges. In the following NGS-based
assays, we screened the HPUF-encoding genes of phage fHy-Eco03. The results of the
plating efficiency and the NGS-based screening assays agreed to great extent (Table 3),
and the same gene products presented toxic and non-toxic effects in both assays, with g05
identified as most toxic in both assays (Table 3), as well as later in the growth inhibition
assay (Figure 4). Despite grossly similar results, the variation between replicates in the NGS
screening assay was substantially lower compared to that of the plating assay (Table S9).
The NGS-based screening assay was designed to increase reliability and significantly
reduce the time and resources required for the hands-on lab work and further analysis of
the results. This was enabled by performing the lab work and bioinformatics analysis of
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the preliminary screening simultaneously for all genes. As seen from the results, variation
between the obtained sequence coverages of replicate transformations and even biological
replicates was very small.
In conclusion, we have introduced here the NGS-based efficient screening assay
for the identification of toxHPUFs. The performance of the assay still relies on very
careful laboratory work when preparing the plasmid vector and the PCR-amplified DNA-
fragments for ligations.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/v13050750/s1, Figure S1: Map of plasmid pU11L4; Figure S2: Transmission electron mi-
crograph of a negatively stained fHy-Eco03 particle; Figure S3: Plaque morphology of E. coli strain
#5509 infected with fHy-Eco03; Figure S4: Growth curves of E. coli strains #5509, #5517, #5520, and
#5522 infected with fHy-Eco03; Figure S5: Restriction enzyme digestion analysis of fHy-Eco03 DNA;
Figure S6: Detection of genome ends of fHy-Eco03; Figure S7: Genomic map of fHy-Eco03; Figure
S8: Genomic comparison of fHy-Eco03; Table S1: E. coli strains used to determine the host range of
fHy-Eco03; Table S2: Annotation of the predicted gene products of fHy-Eco03; Table S3: LC-MS/MS
analysis of the proteome of the fHy-Eco03 virion particles; Table S4: Primers to amplify control genes
encoding toxic and non-toxic gene products; Table S5: Primers used to amplify the HPUF genes of
fHy-Eco03; Table S6: Workflow for the NGS assay bioinformatics; Table S7: Results from plating
assay of control genes; Table S8: Results of the NGS assay with control genes; Table S9: Plating assay
results of 23 HPUF-encoding genes of fHy-Eco03; Table S10: NGS screening of phage fHy-Eco03
HPUF encoding genes.
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